BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3369870)

  • 21. The antitumor effect of MX2, a new morpholino anthracycline, against malignant glioma cell lines and its subcellular distribution.
    Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Kitai R
    Neurosurgery; 1995 Sep; 37(3):471-6; discussion 476-7. PubMed ID: 7501112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of rat glioma with a beta-adrenergic agonist and a phosphodiesterase inhibitor in vivo].
    Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Sakamoto Y; Egawa T
    No To Shinkei; 1987 Aug; 39(8):719-23. PubMed ID: 2827709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
    Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
    Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
    Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
    Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
    Price A; Shi Q; Morris D; Wilcox ME; Brasher PM; Rewcastle NB; Shalinsky D; Zou H; Appelt K; Johnston RN; Yong VW; Edwards D; Forsyth P
    Clin Cancer Res; 1999 Apr; 5(4):845-54. PubMed ID: 10213221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth kinetics and treatment response of the intracerebral rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging.
    Kim B; Chenevert TL; Ross BD
    Clin Cancer Res; 1995 Jun; 1(6):643-50. PubMed ID: 9816027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemotherapy for experimental subarachnoid dissemination model of brain tumor].
    Yamashita T; Shinonaga M; Ishiwata Y; Nishimura S; Murai M; Kyuma Y; Kuwabara T
    No Shinkei Geka; 1984 Jan; 12(1):47-53. PubMed ID: 6585681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vascular endothelial growth factor shRNA mediated by pEGFP-H1 vector plasmid effectively inhibits glioma proliferation: an experimental study].
    Jiang XB; Zhao HY; Zhou F; Liu RE; Zhang FC; Zhao JS
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):547-50. PubMed ID: 15949336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
    Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
    Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Histopathological and autoradiographical studies of experimental brain tumors after continuous local chemotherapy--acute stage in rat models].
    Shimura T; Teramoto A; Aihara K
    Gan To Kagaku Ryoho; 1997 Apr; 24(6):713-8. PubMed ID: 9126309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II study of KRN8602(MX2), a novel morpholino anthracycline derivative, in patients with recurrent malignant glioma.
    Kuratsu J; Arita N; Kurisu K; Uozumi T; Hayakawa T; Ushio Y
    J Neurooncol; 1999 Apr; 42(2):177-81. PubMed ID: 10421076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Overcoming of ACNU resistance in an ACNU-resistant subline of rat C6 glioma in vivo through enhanced effect of ACNU by calmodulin inhibitor].
    Yoshida T; Shimizu K; Hayakawa T; Mogami H; Sakamoto Y; Egawa T
    No Shinkei Geka; 1987 Mar; 15(3):261-7. PubMed ID: 3474542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Distribution and acute toxicity of a new morpholinoanthracycline, MX2, in normal rat brain after intra-arterial injection].
    Izumoto S; Arita N; Hayakawa T; Ohnishi T; Hiraga S; Taki T; Yamamoto H
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):371-5. PubMed ID: 2003739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor effects of erucylphosphocholine on brain tumor cells in vitro and in vivo.
    Erdlenbruch B; Jendrossek V; Marx M; Hunold A; Eibl H; Lakomek M
    Anticancer Res; 1998; 18(4A):2551-7. PubMed ID: 9703909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
    Grommes C; Landreth GE; Sastre M; Beck M; Feinstein DL; Jacobs AH; Schlegel U; Heneka MT
    Mol Pharmacol; 2006 Nov; 70(5):1524-33. PubMed ID: 16887936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.
    Walter KA; Cahan MA; Gur A; Tyler B; Hilton J; Colvin OM; Burger PC; Domb A; Brem H
    Cancer Res; 1994 Apr; 54(8):2207-12. PubMed ID: 7909720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
    Kooistra KL; Rodriguez M; Powis G
    Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Development of ACNU-resistant meningeal gliomatosis models: establishment of resistant rat glioma subline against ACNU].
    Yoshida T; Ushio Y; Hayakawa T; Yamada K; Kato A; Mogami H; Nakata Y
    No Shinkei Geka; 1984 Aug; 12(9):1029-36. PubMed ID: 6594599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
    Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
    Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.